AngioDynamics (ANGO) News
NASDAQ: ANGOHealth CareMedical/Dental InstrumentsUSD
11.52+0.29 (+2.58%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ANGO news summary
We found 12 recent headlines mentioning AngioDynamics (ANGO): 12 in the past week and 12 in the past 30 days, most often from Nasdaq, Seeking Alpha, Investing.com. For price context, ANGO is up 2.58% at $11.52. The most recent story, "AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest AngioDynamics headlines
- AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- AngioDynamics anticipates $336M to $341M FY2027 net sales as CEO transition takes effect November 2Seeking Alpha
- Why AngioDynamics Crashed TodayKey PointsAngioDynamics beat on both top and bottom lines this morning.Nasdaq
- AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEO - Update(RTTNews) - While reporting financial results for the first quarter on Thursday, medical technology company AngioDynamics, Inc. (ANGO) reiterated its adjusted loss and net sales guidance for the full…NasdaqANGO, ET
- AngioDynamics Names Honroth As CEO, Clemmer To Retire; Stock Down In Premarket(RTTNews) - Medical technology company, AngioDynamics, Inc. (ANGO) on Thursday announced the appointment of Eric Honroth as President and Chief Executive Officer (CEO) and a member of its Board of…NasdaqABT, ANGO, BDX, BSX
- Why is AngioDynamics stock sliding today?Investing.com
- AngioDynamics CEO Jim Clemmer to retireSeeking Alpha
- AngioDynamics Inc. Q1 Loss Declines(RTTNews) - AngioDynamics Inc. (ANGO) announced Loss for first quarter of -$7.10 millionNasdaq
- AngioDynamics beats top-line and bottom-line estimates; reaffirms FY26 outlookSeeking Alpha
- AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and ProfitabilityLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system,…Business Wire
- Pre-Market Earnings Report for October 8, 2026 : PEP, NG, ANGO, HELE, TLRY, BYRNThe following companies are expected to report earnings prior to market open on 10/08/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Pepsico, Inc. (PEP)is reporting…NasdaqPEP, NG, ANGO, HELE
- AngioDynamics Q1 2027 Earnings PreviewSeeking Alpha